Every drug that works powerfully enough to treat a disease also works powerfully enough to cause harm. Roughly 6% of patients across medical settings experience preventable harm during their care, and drugs account for the largest single share of those incidents. The danger in medicine is not limited to rare catastrophes or historical tragedies. It is woven into the everyday business of prescribing, dispensing, and taking medications, and understanding where the risks concentrate can help you navigate them.
How Often Does Medicine Actually Hurt People?
A large systematic review pooling data from dozens of studies across hospitals and outpatient settings found that about 6% of patients experience preventable harm, and roughly a quarter of that harm traces directly to drugs. About 12% of preventable harm events were severe or fatal.1PubMed Central. Prevalence, severity, and nature of preventable patient harm across medical care settings: systematic review and meta-analysis A separate meta-analysis focused specifically on medication harm found that about 3% of all patients experience preventable medication harm. The rates climbed in certain settings: roughly 11% among elderly patients, 7% in intensive care, and 6% in surgical settings. About a quarter of preventable medication harm was classified as clinically severe or life-threatening.2PubMed Central. Preventable medication harm across health care settings: a systematic review and meta-analysis
Where in the chain do things go wrong? The same medication-focused review found that prescribing errors were the single biggest source, accounting for about 58% of preventable harm, followed by failures in monitoring at around 47%. That means the danger often is not in the drug itself but in how it gets chosen and tracked. A wrong dose, a missed interaction, or a lab test nobody ordered can turn a safe drug into a dangerous one.
Drugs That Walk a Razor’s Edge
Some medications are inherently riskier because the gap between a dose that helps and a dose that harms is tiny. These are called narrow therapeutic index drugs, and they include familiar names like warfarin (a blood thinner), lithium (a mood stabilizer), digoxin (a heart drug), and certain anti-seizure medications. Because the margin is so slim, they need to be dosed carefully based on blood levels, and patients have to be watched closely for signs of toxicity.3PubMed Central. Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide
What makes narrow therapeutic index drugs especially tricky is that the same dose can produce very different blood levels in different people. While a given person tends to process these drugs in a fairly consistent way from day to day, the variation between individuals is large. That is why one person’s safe dose of lithium could be another person’s toxic dose, and why these drugs require regular blood tests to dial in the right amount for each patient.4Journal of Pharmacy and Pharmacology. Narrow Therapeutic Index drugs: clinical pharmacology perspective In hospital studies, narrow therapeutic index drugs were associated with drug-related problems about 40% of the times they were used, compared to 19% for other medications. The most common issues were wrong dosing, drug interactions, and inadequate monitoring.5PubMed Central. Drugs with narrow therapeutic index as indicators in the risk management of hospitalised patients
When Drugs Collide
Taking multiple medications is the norm for many people, especially older adults. And whenever two or more drugs share the same metabolic pathway in the body, they can interfere with each other in ways that raise toxicity or kill effectiveness. A major family of liver enzymes called cytochrome P450 is responsible for breaking down a huge number of common drugs. When one drug blocks those enzymes, a second drug processed by the same enzymes can build up to dangerous levels. Conversely, a drug that revs up enzyme activity can cause another drug to be cleared so quickly it never reaches a useful concentration.6PubMed Central. Drug interactions due to cytochrome P450
Drug interactions driven by enzyme inhibition are a major cause of hospitalization and death related to medication use.7Biomolecules & Therapeutics. Inhibition of Cytochrome P450 Enzymes by Drugs—Molecular Basis and Practical Applications This is one reason your pharmacist asks for a complete medication list, and why you should always mention supplements and over-the-counter drugs. Grapefruit juice, for example, inhibits one of the same enzyme pathways and can push blood levels of certain statins and blood pressure medications into a harmful range. The interactions are predictable if someone checks, but the checking does not always happen, especially when patients see multiple prescribers who do not communicate with each other.
Historical Disasters That Reshaped Drug Safety
Some of the most dangerous moments in the history of medicine came from substances that were prescribed with confidence before anyone understood the damage they could do. Mercury compounds, particularly calomel (mercurous chloride), were staples of Western medicine for centuries. Doctors prescribed calomel as a laxative, a teething powder for infants, and a treatment for syphilis. The slow accumulation of knowledge about mercury toxicity, from those early medical uses through to the mass methylmercury poisonings in Minamata, Japan, in the mid-twentieth century, reveals how long it can take for a dangerous treatment to be abandoned.8Chemistry at School. Toxicity of Mercury and Its Compounds
Thalidomide is the modern landmark. Marketed in the late 1950s as a safe sedative for pregnant women, it caused severe birth defects in thousands of children before being pulled from the market. The fallout was enormous: it forced the United States and other countries to overhaul how drugs are tested before reaching patients. New regulations required systematic toxicity testing, expanded informed consent procedures, and greater transparency from pharmaceutical companies.9PubMed Central. The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development Research into why thalidomide caused those birth defects also led to significant advances in understanding how limbs develop at a molecular level, and the drug itself was eventually repurposed, under strict controls, for treating certain cancers and leprosy complications.10PubMed. Thalidomide: the tragedy of birth defects and the effective treatment of disease
Off-Label Prescribing and Its Blind Spots
Doctors are legally permitted to prescribe a drug for any purpose they believe is medically justified, even if that use was never tested or approved by regulators. This is called off-label prescribing, and it is extremely common. Sometimes it is well supported by evidence. Other times, it amounts to a best guess. A large study tracking adult patients found that off-label use without strong scientific evidence carried a roughly 54% higher risk of adverse drug events compared with on-label use. When off-label use was backed by strong evidence, the risk was statistically no different from on-label use.11JAMA Internal Medicine. Association of Off-label Drug Use and Adverse Drug Events in an Adult Population
The distinction matters: off-label prescribing itself is not the problem, but off-label prescribing without good evidence behind it is. When patients benefit from off-label use, it is typically because the supporting science, while not reflected in the drug’s formal approval, is solid. When there is no such evidence, the patient is essentially an unacknowledged test subject.12PubMed Central. Off-label prescribing: a call for heightened professional and government oversight Children face this risk disproportionately, since many existing drug formulations were never designed or tested for pediatric use, which often pushes prescribers into off-label territory with less evidence to guide dosing and safety.13PubMed Central. Off-Label, but on-Evidence? A Review of the Level of Evidence for Pediatric Pharmacotherapy
Opioids and the Biology of Overdose
Opioid painkillers such as morphine, oxycodone, and fentanyl kill primarily by shutting down breathing. They slow the respiratory rate by acting on brainstem centers that control the rhythm and drive of breathing, including both the circuits that generate each breath and the sensors that detect rising carbon dioxide. They also dampen the wakeful awareness that normally helps sustain breathing during sleep or sedation.14PubMed Central. Multi-Level Regulation of Opioid-Induced Respiratory Depression This means a person who takes too much of an opioid, or who combines an opioid with another sedating drug like alcohol or a benzodiazepine, can simply stop breathing. The danger is amplified by tolerance: regular users need higher doses for pain relief, but the body’s tolerance to the respiratory-depressing effects does not keep pace with tolerance to the pain-relieving effects.
Fentanyl and its analogs have added a newer dimension of danger. Because fentanyl is active in microgram quantities, tiny errors in dosing, whether in illicit production or even in clinical settings, can be fatal. The margin between a therapeutic dose and a lethal one is narrower than with older opioids, which is a major reason fentanyl now drives the bulk of overdose deaths in many countries.
Benzodiazepines and the Trap of Dependence
Benzodiazepines like diazepam (Valium), alprazolam (Xanax), and lorazepam (Ativan) are prescribed widely for anxiety, insomnia, and seizures. They work quickly and effectively. They can also create physical dependence even at therapeutic doses, and stopping them abruptly after prolonged use triggers a withdrawal syndrome that can include anxiety, insomnia, tremor, sweating, nausea, and in severe cases, seizures and psychotic reactions.15PubMed. The benzodiazepine withdrawal syndrome A clinically distinct withdrawal reaction occurs after long-term therapeutic use, not just after high-dose misuse, a fact that was formally established decades ago and remains well recognized.16PubMed. Withdrawal Reaction after Long-Term Therapeutic Use of Benzodiazepines
Beyond withdrawal, long-term benzodiazepine use is associated with cognitive decline and an increased risk of falls, especially in older adults.17PubMed Central. Management of benzodiazepine misuse and dependence The combination of physical dependence, difficulty stopping, and ongoing cognitive harm makes benzodiazepines a case study in how a drug that is genuinely useful in the short term becomes dangerous when continued indefinitely. Many prescribing guidelines now recommend limiting benzodiazepine courses to a few weeks, but in practice, long-term prescriptions remain common.
Liver Damage from Common Drugs
Your liver bears the brunt of drug metabolism, and sometimes the process itself produces toxic byproducts. Drug-induced liver injury can be caused by prescription drugs, over-the-counter painkillers, and herbal supplements alike. Acetaminophen (paracetamol) is the most familiar culprit: it is safe at recommended doses, but overdose, even an unintentional one from combining multiple acetaminophen-containing products, is the leading cause of acute liver failure in many Western countries. Most cases of drug-induced liver injury improve when the offending drug is stopped, which makes early recognition critical.18PubMed Central. Drug-induced Liver Injury
Other medications known to carry liver risks include certain antibiotics, anti-tuberculosis drugs, statins at high doses, and some anti-seizure medications. The tricky part is that drug-induced liver injury is often idiosyncratic: it does not always depend on dose, and it can strike unpredictably in people who have taken the same drug for months without issues. This is why routine liver function tests are part of monitoring for several chronic medications.
Severe Allergic Reactions and Skin Destruction
At the extreme end of drug hypersensitivity sit Stevens-Johnson syndrome and toxic epidermal necrolysis, two conditions on a spectrum in which the skin and mucous membranes blister and peel off. These are rare but life-threatening, with high mortality rates especially in older patients and those with extensive skin involvement.19PubMed Central. Clinical features, outcomes and treatment in children with drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis Common triggers include certain antibiotics, anti-seizure drugs like carbamazepine and lamotrigine, and the gout medication allopurinol.20PubMed Central. Fatal Case of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Induced by Doxycycline or Flucloxacillin in a 77-Year-Old Woman: A Rare but Serious Adverse Drug Reaction
These reactions are considered a late-onset allergic response, typically appearing one to three weeks after starting a new medication. Genetic risk factors have been identified for some drug-reaction pairings. In parts of Southeast Asia, for instance, genetic screening before prescribing carbamazepine has become standard because carriers of certain gene variants face a dramatically higher risk. Even in populations without known genetic predispositions, any new drug that causes a spreading rash with mucosal involvement (sores in the mouth, eyes, or genitals) should be treated as a medical emergency.
Counterfeit and Substandard Drugs
Not every dangerous medicine starts in a legitimate pharmacy. Counterfeit and substandard drugs represent an enormous global health threat, especially in regions with weaker regulatory infrastructure. What makes them so hazardous is the complete absence of quality control: they may contain no active ingredient, the wrong ingredient, or wildly unpredictable amounts of the right one.21PubMed. Health risks of counterfeit pharmaceuticals A review of published reports identified 48 significant incidents involving falsified medicines, producing approximately 7,200 casualties, including over 3,600 deaths. While most incidents occurred in developing countries, more than 40% were in developed nations, so the problem is not confined to low-income settings.22PubMed. The health consequences of falsified medicines- A study of the published literature
Counterfeit antibiotics are especially destructive on a population level. An antibiotic with too little active ingredient exposes bacteria to sub-lethal concentrations, which is exactly the condition that breeds drug-resistant strains. That links the counterfeit drug problem directly to the wider crisis of antimicrobial resistance, which has been accelerated by antibiotic overuse and misuse globally.23PubMed Central. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem
Herbal Remedies and Heavy Metal Contamination
Products marketed as natural alternatives to conventional medicine operate under looser regulatory frameworks in most countries, and that gap creates its own hazards. A global analysis of nearly 1,800 herbal medicine samples found that about 30% contained at least one heavy metal above pharmacopeia safety limits. Lead exceeded limits in nearly 6% of samples, cadmium in about 5%, and arsenic, mercury, and copper each in smaller proportions. Twenty-five types of herbs posed an unacceptable health risk based on estimated daily intake of those metals.24PubMed Central. Heavy Metal Contaminations in Herbal Medicines: Determination, Comprehensive Risk Assessments, and Solutions
The contamination usually comes from the soil and water where plants are grown, but in some cases heavy metals are added intentionally as part of traditional preparation methods. Lead, mercury, and arsenic have no safe threshold of chronic exposure, so even modest contamination in a product taken daily becomes cumulative. Consumers often assume “natural” means safe, but the absence of the quality controls applied to pharmaceutical manufacturing means herbal products can carry risks that conventional drugs, for all their problems, are at least tested and monitored for.
When the Danger Is the Point
Some of the most dangerous medicines in clinical use are dangerous by design. Cytotoxic chemotherapy drugs work by killing rapidly dividing cells, but they cannot reliably distinguish cancer cells from normal tissue. That non-specificity is the central drawback of chemotherapy: it damages the gut lining, bone marrow, hair follicles, and other rapidly renewing tissues along with the tumor.25Medicine. Systemic Therapy Cytotoxic chemotherapy: clinical aspects Patients accept severe side effects because the alternative, untreated cancer, is worse. But cure with chemotherapy alone remains uncommon for many cancer types, and the toxicity limits how aggressively clinicians can dose.
Newer approaches like CAR-T cell therapy, which engineers a patient’s own immune cells to attack cancer, were designed to be more targeted. They have produced remarkable responses in certain blood cancers. But they also carry a distinctive danger: cytokine release syndrome, in which the immune system overreacts massively, causing high fevers, dangerously low blood pressure, and organ damage. If uncontrolled, it can be fatal.26PubMed Central. Controlling Cytokine Release Syndrome to Harness the Full Potential of CAR-Based Cellular Therapy The progress from blunt-force chemotherapy to precision immunotherapy has been real, but each generation of cancer treatment trades one set of dangers for another.
How Black Box Warnings and Post-Market Surveillance Work
No amount of pre-approval testing can catch every danger. Clinical trials involve thousands of patients at most, while a newly approved drug may reach millions. Rare adverse effects, slow-onset harms, and interactions with drugs that were not studied in the trial all surface after approval. That is why post-market surveillance exists. In the United States, the most serious safety signal a drug can receive is a black box warning, the boldly bordered alert on the prescribing label. Evidence for these warnings comes predominantly from post-marketing studies rather than from the original clinical trials.27PubMed Central. A Longitudinal Analysis of Black Box Warnings: Trends and Implications for Drug Safety
The system depends partly on voluntary adverse event reports from clinicians and patients, and that introduces blind spots. Reporting patterns are influenced by the severity of the event and by whether a related warning already exists. That kind of feedback loop means the system is better at confirming known dangers than at uncovering new ones. Regulators increasingly recognize the need for proactive surveillance strategies that do not rely solely on spontaneous reports.28PubMed. Evaluating the Impact of Black Box Warning Updates on the Reporting of Drug-Related Adverse Events: a Cross Sectional Study of the FAERS Database Electronic health records, large insurance claims databases, and international safety-signal sharing networks are increasingly used to detect patterns that voluntary reporting alone would miss.
Antibiotics and the Slow-Motion Threat of Resistance
Most discussions of dangerous medicine focus on direct, visible harm: an overdose, a toxic reaction, a birth defect. Antibiotic resistance is a different kind of danger, one that is collective rather than individual and accumulates over years. Every course of antibiotics, whether prescribed appropriately or not, exerts selective pressure on bacteria. Overuse and misuse of antibiotics worldwide have accelerated the rise of resistant organisms to the point that some infections have become extremely difficult or impossible to treat with existing drugs.29PubMed Central. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem
The danger here is paradoxical. Antibiotics are one of the most important medical advances in human history. But by using them too freely, for viral infections they cannot treat, in livestock feed to promote growth, and in courses that patients abandon halfway through, we are eroding their effectiveness for future patients. Drug-resistant tuberculosis, methicillin-resistant Staphylococcus aureus (MRSA), and carbapenem-resistant gram-negative bacteria are already realities in hospitals around the world. An antibiotic prescribed carelessly today can contribute to a death from an untreatable infection years from now, a chain of causation that makes it uniquely difficult to feel the danger in the moment.